S212-0475 Screening compound: (3-ethyl-1,2,4-oxadiazol-5-yl)methyl [1-(2-pyridylmethyl)-3-piperidyl] ether

S212-0475 Screening compound: (3-ethyl-1,2,4-oxadiazol-5-yl)methyl [1-(2-pyridylmethyl)-3-piperidyl] ether
S212-0475 Screening compound: (3-ethyl-1,2,4-oxadiazol-5-yl)methyl [1-(2-pyridylmethyl)-3-piperidyl] ether alternative view

Chemical Structure Depiction of ChemDiv screening compound S212-0475
(3-ethyl-1,2,4-oxadiazol-5-yl)methyl [1-(2-pyridylmethyl)-3-piperidyl] ether

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S212-0475

Molecular Formula

C16H22N4O2 (C16 H22 N4 O2)

Compound Name

(3-ethyl-1,2,4-oxadiazol-5-yl)methyl [1-(2-pyridylmethyl)-3-piperidyl] ether

IUPAC name

2-({3-[(3-ethyl-124-oxadiazol-5-yl)methoxy]piperidin-1-yl}methyl)pyridine

SMILES

CCc1noc(COC2CN(Cc3ncccc3)CCC2)n1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

302.38

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.451

Distribution Coefficient, logD

1.222

Water Solubility, LogSw

-1.64

Polar Surface Area

52.794

Acid Dissociation Constant (pKa)

26.02

Base Dissociation Constant (pKb)

7.24

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

56.25

S212-0475 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Soluble Diversity Library (15920 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds
Agro:
  • Agro

References: we are preparing a list of scientific research reports with S212-0475 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S212-0475?
Check Price and Availability of S212-0475, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S212-0475 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S212-0475
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S212-0475
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S212-0475 available by request